Curcumin suppresses migration and invasion of human endometrial carcinoma cells

Chen,Qian; Gao,Qing; Chen,Kunlun; Wang,Yidong; Chen,Lijuan; Li,Xu

doi:10.3892/ol.2015.3478

Curcumin suppresses migration and invasion of human endometrial carcinoma cells

Authors:
- Qian Chen
- Qing Gao
- Kunlun Chen
- Yidong Wang
- Lijuan Chen
- Xu Li
View Affiliations

Affiliations: Department of Obstetrics and Gynecology, The Second Affiliated Hospital, Medical School of Xi'an Jiaotong University, Xi'an, Shaanxi 710004, P.R. China, Center for Translational Medicine, The First Affiliated Hospital, Medical School of Xi'an Jiaotong University, Xi'an, Shaanxi 710061, P.R. China
Published online on: July 9, 2015 https://doi.org/10.3892/ol.2015.3478
Pages: 1297-1302
Copyright: © Chen et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Curcumin, a widely used Chinese herbal medicine, has historically been used in anti-cancer therapies. However, the anti-metastatic effect and molecular mechanism of curcumin in endometrial carcinoma (EC) are still poorly understood. The purpose of this study was to detect the anti‑metastatic effects of curcumin and the associated mechanism(s) in EC. Based on assays carried out in EC cell lines, it was observed that curcumin inhibited EC cell migration and invasion in vitro. Furthermore, following treatment with curcumin for 24 h, there was a decrease in the expression levels of matrix metalloproteinase (MMP)‑2 and ‑9 as well as proteinase activity in EC cells. Moreover, curcumin treatment significantly decreased the levels of the phosphorylated form of extracellular signal-regulated kinase (ERK) 1/2. MEK1 overexpression partially blocked the anti‑metastatic effects of curcumin. Combined treatment with ERK inhibitor U0126 and curcumin resulted in a synergistic reduction in MMP‑2/‑9 expression; the invasive capabilities of HEC‑1B cells were also inhibited. In conclusion, curcumin inhibits tumor cell migration and invasion by reducing the expression and activity of MMP-2/9 via the suppression of the ERK signaling pathway, suggesting that curcumin is a potential therapeutic agent for EC.

View Figures

View References

1	Kitchener HC and Trimble EL: Endometrial cancer state of the science meeting. Int J Gynecol Cancer. 19:134–140. 2009. View Article : Google Scholar : PubMed/NCBI
2	Sorosky JI: Endometrial cancer. Obstet Gynecol. 111:436–447. 2008. View Article : Google Scholar : PubMed/NCBI
3	Barrena Medel NI, Bansal S, Miller DS, Wright JD and Herzog TJ: Pharmacotherapy of endometrial cancer. Expert Opin Pharmacother. 10:1939–1951. 2009. View Article : Google Scholar : PubMed/NCBI
4	Chen K, Zhang S, Ji Y, et al: Baicalein inhibits the invasion and metastatic capabilities of hepatocellular carcinoma cells via down-regulation of the ERK pathway. PLoS One. 8:e729272013. View Article : Google Scholar : PubMed/NCBI
5	Weigel MT, Krämer J, Schem C, et al: Differential expression of MMP-2, MMP-9 and PCNA in endometriosis and endometrial carcinoma. Eur J Obstet Gynecol Reprod Biol. 160:74–78. 2012. View Article : Google Scholar : PubMed/NCBI
6	Karahan N, Güney M, Baspinar S, Oral B, Kapucuoglu N and Mungan T: Expression of gelatinase (MMP-2 and MMP-9) and cyclooxygenase-2 (COX-2) in endometrial carcinoma. Eur J Gynaecol Oncol. 28:184–188. 2007.PubMed/NCBI
7	Naksuriya O, Okonogi S, Schiffelers RM and Hennink WE: Curcumin nanoformulations: a review of pharmaceutical properties and preclinical studies and clinical data related to cancer treatment. Biomaterials. 35:3365–3383. 2014. View Article : Google Scholar : PubMed/NCBI
8	Likhter MS, Shelygin Iu A and Achkasov SI: Multidisciplinary approach to the treatment of colorectal cancer, complicated by urinary tract invasion. Khirurgiia (Mosk). 12:34–39. 2012.(In Russian). PubMed/NCBI
9	Chen J, Wang FL and Chen WD: Modulation of apoptosis-related cell signalling pathways by curcumin as a strategy to inhibit tumor progression. Mol Biol Rep. 41:4583–4594. 2014. View Article : Google Scholar : PubMed/NCBI
10	Wong TF, Takeda T, Li B, et al: Curcumin targets the AKT-mTOR pathway for uterine leiomyosarcoma tumor growth suppression. Int J Clin Oncol. 19:354–363. 2014. View Article : Google Scholar : PubMed/NCBI
11	Ranjan AP, Mukerjee A, Helson L, Gupta R and Vishwanatha JK: Efficacy of liposomal curcumin in a human pancreatic tumor xenograft model: inhibition of tumor growth and angiogenesis. Anticancer Res. 33:3603–3609. 2013.PubMed/NCBI
12	Liang YJ, Hao Q, Wu YZ, Wang QL, Wang JD and Hu YL: Aromatase inhibitor letrozole in synergy with curcumin in the inhibition of xenografted endometrial carcinoma growth. Int J Gynecol Cancer. 19:1248–1252. 2009. View Article : Google Scholar : PubMed/NCBI
13	Yu Z and Shah DM: Curcumin down-regulates Ets-1 and Bcl-2 expression in human endometrial carcinoma HEC-1-A cells. Gynecol Oncol. 106:541–548. 2007. View Article : Google Scholar : PubMed/NCBI
14	Sun W, Liu DB, Li WW, et al: Interleukin-6 promotes the migration and invasion of nasopharyngeal carcinoma cell lines and upregulates the expression of MMP-2 and MMP-9. Int J Oncol. 44:1551–1560. 2014.PubMed/NCBI
15	Park SL, Lee EJ, Kim WJ and Moon SK: p27KIP1 is involved in ERK1/2-mediated MMP-9 expression via the activation of NF-κB binding in the IL-7-induced migration and invasion of 5637 cells. Int J Oncol. 44:1349–1356. 2014.PubMed/NCBI
16	Lee KR, Lee JS, Kim YR, Song IG and Hong EK: Polysaccharide from Inonotus obliquus inhibits migration and invasion in B16-F10 cells by suppressing MMP-2 and MMP-9 via downregulation of NF-κB signaling pathway. Oncol Rep. 31:2447–2453. 2014.PubMed/NCBI
17	Lin HJ, Su CC, Lu HF, et al: Curcumin blocks migration and invasion of mouse-rat hybrid retina ganglion cells (N18) through the inhibition of MMP-2, -9, FAK, Rho A and Rock-1 gene expression. Oncol Rep. 23:665–670. 2010.PubMed/NCBI
18	Qi Q, Dai M, Fan H, Zhang B and Yuan X: Inhibitory effect of curcumin on MMP-2 and MMP-9 expression induced by polyethylene wear particles and its mechanism. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 23:677–682. 2009.(In Chinese). PubMed/NCBI
19	Mitra A, Chakrabarti J, Banerji A, Chatterjee A and Das BR: Curcumin, a potential inhibitor of MMP-2 in human laryngeal squamous carcinoma cells HEp2. J Environ Pathol Toxicol Oncol. 25:679–690. 2006. View Article : Google Scholar : PubMed/NCBI
20	Banerji A, Chakrabarti J, Mitra A and Chatterjee A: Effect of curcumin on gelatinase A (MMP-2) activity in B16F10 melanoma cells. Cancer Lett. 211:235–242. 2004. View Article : Google Scholar : PubMed/NCBI
21	Hoshino R, Chatani Y, Yamori T, et al: Constitutive activation of the 41-/43-kDa mitogen-activated protein kinase signaling pathway in human tumors. Oncogene. 18:813–822. 1999. View Article : Google Scholar : PubMed/NCBI
22	Wang Y, Zhu Y, Zhang L, et al: Insulin promotes proliferation, survival and invasion in endometrial carcinoma by activating the MEK/ERK pathway. Cancer Lett. 322:223–231. 2012. View Article : Google Scholar : PubMed/NCBI
23	Tong JS, Zhang QH, Wang ZB, et al: ER-α36, a novel variant of ER-α, mediates estrogen-stimulated proliferation of endometrial carcinoma cells via the PKCδ/ERK pathway. PLoS One. 5:e154082010. View Article : Google Scholar : PubMed/NCBI
24	Zhang H, Shen B, Swinarska JT, Li W, Xiao K and He P: 9-Hydroxypheophorbide α-mediated photodynamic therapy induces matrix metalloproteinase-2 (MMP-2) and MMP-9 down-regulation in Hep-2 cells via ROS-mediated suppression of the ERK pathway. Photodiagnosis Photodyn Ther. 11:55–62. 2014. View Article : Google Scholar : PubMed/NCBI
25	Shi MD, Shih YW, Lee YS, Cheng YF and Tsai LY: Suppression of 12-O-tetradecanoylphorbol-13-acetate-induced MCF-7 breast adenocarcinoma cells invasion/migration by α-tomatine through activating PKCα/ERK/NF-κB-dependent MMP-2/MMP-9 expressions. Cell Biochem Biophys. 66:161–174. 2013. View Article : Google Scholar : PubMed/NCBI
26	Dong QZ, Wang Y, Tang ZP, et al: Derlin-1 is overexpressed in non-small cell lung cancer and promotes cancer cell invasion via EGFR-ERK-mediated up-regulation of MMP-2 and MMP-9. Am J Pathol. 182:954–964. 2013. View Article : Google Scholar : PubMed/NCBI
27	Guo Y, Shan Q, Gong Y, et al: Curcumin induces apoptosis via simultaneously targeting AKT/mTOR and RAF/MEK/ERK survival signaling pathways in human leukemia THP-1 cells. Pharmazie. 69:229–233. 2014.PubMed/NCBI
28	Xie YQ, Wu XB and Tang SQ: Curcumin treatment alters ERK-1/2 signaling in vitro and inhibits nasopharyngeal carcinoma proliferation in mouse xenografts. Int J Clin Exp Med. 7:108–114. 2014.PubMed/NCBI
29	Mo N, Li ZQ, Li J and Cao YD: Curcumin inhibits TGF-β1-induced MMP-9 and invasion through ERK and Smad signaling in breast cancer MDA-MB-231 cells. Asian Pac J Cancer Prev. 13:5709–5714. 2012. View Article : Google Scholar : PubMed/NCBI
30	Shin HK, Kim J, Lee EJ and Kim SH: Inhibitory effect of curcumin on motility of human oral squamous carcinoma YD-10B cells via suppression of ERK and NF-kappaB activations. Phytother Res. 24:577–582. 2010.PubMed/NCBI